Heart Test Laboratories, Inc. HSCS 深 沪
等待开盘 12-16 09:30:00 美东时间
2.47
-0.080
-3.14%
华盛通- 最 高2.83
- 今 开2.83
- 成交量 45.21万股
- 最 低 2.42
- 昨 收 2.55
- 总市值 758.19万
- 52周最高 6.47
- 市盈率 静 --
- 换手率 14.73%
- 52周最低 2.01
- 委 比 -95.00%
- 总股本 306.96万
- 历史最高 600.00
- 量 比 10.79
- 振 幅 16.08%
- 历史最低 2.01
- 每 手 1
- 风险率 0.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HeartSciences shares are trading higher after the company reported better-than-expected Q2 EPS results.
HeartSciences shares are trading higher after the company reported better-than-...
今天 05:31
CORRECTION: Heart Test Laboratories Q2 EPS $(0.85) Beats $(1.69) Estimate, Sales $2.419K Miss $50.000K Estimate
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.69) by 49.7 percent. This is a 62.56 percent increase over losses of $(2.27) per share
今天 05:24
港股红利代表·恒生央企ETF(513170)涨超1.7%创新高，国有”三资“管理深化
消息面上，近期湖北、湖南等省份召开深化国有“三资”管理相关会议，主要内容包括深刻把握“一切国有资源尽可能资产化、一切国有资产尽可能证券化、一切国有资金尽可能杠杆...
10-21 10:12
恒生央企ETF(513170)红盘向上，市场波动加剧高股息资产优势凸显
截至2025年10月16日13:27，恒生央企ETF(513170)上涨0.40%，最新价报1.52元。 消息面上，随着近期国际贸易摩擦升级，市场风...
10-16 13:48
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
Heart Test Laboratories Announces Successful Regulation A Offering
Heart Test Laboratories, Inc. ( ($HSCS) ) has shared an announcement. Heart Tes...
10-02 05:48
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $9.
10-01 18:27
Heart Test Laboratories Regains Nasdaq Compliance
Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. On September ...
09-18 05:22
HeartSciences GAAP EPS of -$1.58
HeartSciences press release (NASDAQ:HSCS): Q1 GAAP EPS of -$1.58. More on HeartSciences Seeking Alpha’s Quant Rating on HeartSciences Historical earnings data for HeartSciences Financial information f...
09-13 01:39
Heart Test Laboratories Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(2.09) by 24.4 percent. This is a 40.15 percent increase over losses of $(2.64) per share
09-12 04:19
